|
EP0889122A3
(en)
*
|
1993-11-30 |
1999-03-03 |
McGILL UNIVERSITY |
Inhibition of DNA Methyltransferase
|
|
US6645943B1
(en)
|
1994-10-25 |
2003-11-11 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
|
US6608035B1
(en)
|
1994-10-25 |
2003-08-19 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
|
US7074768B2
(en)
|
1995-08-17 |
2006-07-11 |
Idera Pharmaceuticals, Inc. |
Modified protein kinase A-specific oligonucleotides and methods of their use
|
|
CA2256305A1
(en)
*
|
1996-05-22 |
1997-11-27 |
Mcgill University |
Specific inhibitors of dna methyltransferase enzyme
|
|
US6268137B1
(en)
|
1996-05-22 |
2001-07-31 |
Methylgene, Inc. |
Specific inhibitors of DNA methyl transferase
|
|
WO1998003646A1
(en)
*
|
1996-07-22 |
1998-01-29 |
Hybridon, Inc. |
Compositions and methods for treating specific gene expression-related diseases and disorders in humans
|
|
AU8125098A
(en)
|
1997-05-30 |
1998-12-30 |
Mcgill University |
Dna methyltransferase genomic sequences and antisense oligonucleotides
|
|
US6020318A
(en)
*
|
1997-05-30 |
2000-02-01 |
Methylgene, Inc. |
DNA methyltransferase genomic sequences and antisense oligonucleotides
|
|
US7138384B1
(en)
*
|
1997-08-29 |
2006-11-21 |
The Regents Of The University Of California |
Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
|
|
ATE294388T1
(de)
*
|
1997-08-29 |
2005-05-15 |
Univ California |
Modulatoren der cytosin-5-methyl-transferase und verfahren zu ihrer verwendung
|
|
US6506559B1
(en)
*
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
US6066625A
(en)
*
|
1998-02-03 |
2000-05-23 |
Methylgene, Inc. |
Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences
|
|
BRPI9908967B1
(pt)
|
1998-03-20 |
2017-05-30 |
Benitec Australia Ltd |
processos para reprimir, retardar ou de outro modo reduzir a expressão de um gene alvo em uma célula de planta
|
|
AUPP249298A0
(en)
*
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
US7342108B2
(en)
*
|
1998-06-25 |
2008-03-11 |
The General Hospital Corporation |
De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
|
|
US7368551B2
(en)
|
1998-06-25 |
2008-05-06 |
The General Hospital Corporation |
De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
|
|
EP1108018A1
(en)
*
|
1998-08-31 |
2001-06-20 |
AstraZeneca AB |
Human deltex-like gene zdx
|
|
US6953783B1
(en)
*
|
1998-10-19 |
2005-10-11 |
Methylgene, Inc. |
Modulation of gene expression by combination therapy
|
|
EP1829856A3
(en)
|
1998-11-12 |
2009-02-25 |
Invitrogen Corporation |
Transfection reagents
|
|
WO2000044914A1
(en)
*
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
|
CA2370628A1
(en)
*
|
1999-04-21 |
2000-10-26 |
American Home Products Corporation |
Methods and compositions for inhibiting the function of polynucleotide sequences
|
|
US20040138168A1
(en)
*
|
1999-04-21 |
2004-07-15 |
Wyeth |
Methods and compositions for inhibiting the function of polynucleotide sequences
|
|
US20030078216A1
(en)
*
|
1999-05-03 |
2003-04-24 |
Macleod A. Robert |
Inhibition of histone deactylase
|
|
US6423885B1
(en)
|
1999-08-13 |
2002-07-23 |
Commonwealth Scientific And Industrial Research Organization (Csiro) |
Methods for obtaining modified phenotypes in plant cells
|
|
EP1130120A3
(en)
*
|
2000-01-26 |
2004-02-04 |
Nisshinbo Industries, Inc. |
Method for separating and collecting nucleic acids
|
|
JP2003527856A
(ja)
*
|
2000-03-17 |
2003-09-24 |
ベニテック オーストラリア リミテッド |
遺伝子のサイレンシング
|
|
EP1438404A2
(en)
|
2000-03-24 |
2004-07-21 |
Methylgene, Inc. |
Inhibition of specific histone deacetylase isoforms
|
|
ATE450621T2
(de)
*
|
2000-03-30 |
2009-12-15 |
Whitehead Biomedical Inst |
Mediatoren von rns-interferenz, die rns- sequenzspezifisch sind
|
|
US20040006036A1
(en)
*
|
2000-04-12 |
2004-01-08 |
Gmr, A Delaware Corporation |
Silencing transcription by methylation
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
AU9684601A
(en)
|
2000-10-12 |
2002-04-22 |
Univ Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
WO2002034879A2
(en)
*
|
2000-10-27 |
2002-05-02 |
Invitrogen Corporation |
Method for introducing antisense oligonucleotides into eucaryotic cells
|
|
KR100872437B1
(ko)
*
|
2000-12-01 |
2008-12-05 |
막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. |
Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
|
|
CA2369944A1
(en)
*
|
2001-01-31 |
2002-07-31 |
Nucleonics Inc. |
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
|
|
EA200301142A1
(ru)
*
|
2001-04-20 |
2004-02-26 |
Уайт |
Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
|
|
IL158448A0
(en)
*
|
2001-04-20 |
2004-05-12 |
Wyeth Corp |
Heterocyclylalkoxy- alkylthio-and-alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
US20030083292A1
(en)
*
|
2001-05-11 |
2003-05-01 |
Macleod Alan Robert |
Inhibitors of DNA methyltransferase isoforms
|
|
US20040266718A1
(en)
*
|
2001-08-06 |
2004-12-30 |
Zuomei Li |
Inhibition of specific histone deacetylase isoforms
|
|
US7811992B2
(en)
|
2002-02-06 |
2010-10-12 |
Stasys Technologies, Inc. |
Anti-infarction molecules
|
|
EP1534729A2
(en)
*
|
2002-02-26 |
2005-06-01 |
University of Utah Research Foundation |
Variants of nedd4l associated with hypertension and viral budding
|
|
EP2116604A1
(en)
|
2002-08-05 |
2009-11-11 |
University of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
|
ITMI20031714A1
(it)
*
|
2003-09-05 |
2005-03-06 |
Gentium Spa |
Formazioni ad azione antitumorale.
|
|
US7855323B2
(en)
|
2004-02-10 |
2010-12-21 |
Monsanto Technology Llc |
Recombinant DNA for gene suppression
|
|
US20060075515A1
(en)
|
2004-08-11 |
2006-04-06 |
Luethy Michael H |
Enhanced zein reduction in transgenic corn seed
|
|
EP1574499A1
(en)
*
|
2004-03-08 |
2005-09-14 |
DKFZ Deutsches Krebsforschungszentrum |
Inhibitors of DNA methylation in tumor cells
|
|
AU2005247319B2
(en)
*
|
2004-04-28 |
2011-12-01 |
Molecules For Health, Inc. |
Methods for treating or preventing restenosis and other vascular proliferative disorders
|
|
MX2007008065A
(es)
*
|
2004-12-30 |
2008-03-04 |
Todd M Hauser |
Composiciones y metodos para modular la expresion genica usando oligonucleotidos autoprotegidos.
|
|
EP1855697A2
(en)
*
|
2005-03-03 |
2007-11-21 |
Gentium Spa |
Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors
|
|
DE202005004135U1
(de)
*
|
2005-03-11 |
2005-05-19 |
Klocke Verpackungs-Service Gmbh |
Mehrkomponentenverpackung mit Applikator
|
|
EP3312196B1
(en)
|
2005-03-23 |
2019-07-17 |
Genmab A/S |
Antibodies against cd38 for treatment of multiple myeloma
|
|
US7476733B2
(en)
|
2005-03-25 |
2009-01-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease
|
|
US20060252723A1
(en)
*
|
2005-04-01 |
2006-11-09 |
Methylgene, Inc. The Cleveland Clinic Foundation |
Combined therapy utilizing reduction of DNA methyltransferase expression and/or activity and interferon
|
|
JP5148499B2
(ja)
*
|
2005-05-20 |
2013-02-20 |
メチルジーン インコーポレイテッド |
Ｖｅｇｆ受容体およびｈｇｆ受容体シグナル伝達の阻害剤
|
|
EP2395076A1
(en)
|
2005-10-14 |
2011-12-14 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
WO2007107005A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Methylgene, Inc. |
Inhibitors of protein tyrosine kinase activity
|
|
US20080004273A1
(en)
*
|
2006-05-30 |
2008-01-03 |
Stephane Raeppel |
Inhibitors of protein tyrosine kinase activity
|
|
EP1872787A1
(en)
*
|
2006-06-27 |
2008-01-02 |
Gentium S.p.A. |
Use of defibrotide for the inhibition of heparanase
|
|
EP3034083B1
(en)
|
2006-09-21 |
2020-12-09 |
University of Rochester |
Antisense oligonucleotides for use in treating myotonic dystrophy
|
|
WO2008046216A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Methylgene, Inc. |
Kinase inhibitors and uses thereof
|
|
EP2104516B1
(en)
|
2006-11-01 |
2015-01-07 |
University of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
|
CN101600451A
(zh)
|
2006-12-11 |
2009-12-09 |
犹他大学研究基金会 |
用于治疗病理性血管生成和血管通透性的组合物和方法
|
|
EP1982722A1
(en)
*
|
2007-04-16 |
2008-10-22 |
Gentium S.p.A. |
Use of oligotide for the treatment of renal diseases
|
|
EP2030615A3
(en)
*
|
2007-08-13 |
2009-12-02 |
ELFORD, Howard L. |
Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases
|
|
US8557767B2
(en)
|
2007-08-28 |
2013-10-15 |
Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
|
EP2195331B1
(en)
|
2007-08-28 |
2013-11-20 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
CA2706317C
(en)
*
|
2007-12-03 |
2017-06-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Doc1 compositions and methods for treating cancer
|
|
EP2103689A1
(en)
*
|
2008-03-19 |
2009-09-23 |
Gentium S.p.A. |
Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
|
|
WO2009137686A1
(en)
|
2008-05-08 |
2009-11-12 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
CA2734322A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
CA2740746A1
(en)
|
2008-10-14 |
2010-04-22 |
Ning Xi |
Compounds comprising a spiro-ring and and methods of use
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
US20110060000A1
(en)
|
2009-09-10 |
2011-03-10 |
Maurizio Grimaldi |
Acridine analogs in the treatment of gliomas
|
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
|
EP2580243B1
(en)
|
2010-06-09 |
2019-10-16 |
Genmab A/S |
Antibodies against human cd38
|
|
EP2637672B1
(en)
|
2010-11-12 |
2018-08-22 |
Gentium S.r.l. |
Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
|
|
RU2568258C2
(ru)
|
2011-02-28 |
2015-11-20 |
Саншайн Лейк Фарма Ко., Лтд |
Замещенные соединения хинолина и способы их использования
|
|
JP2013198425A
(ja)
*
|
2012-03-24 |
2013-10-03 |
Kanagawa Univ |
オリゴヌクレオチドの製造方法
|
|
KR102038357B1
(ko)
|
2012-06-22 |
2019-10-31 |
젠티엄 에스알엘 |
디파이브로타이드의 생물학적 활성 측정을 위한 유우글로불린에 기초한 방법
|
|
JP6342392B2
(ja)
|
2012-07-28 |
2018-06-13 |
カリター・サイエンシーズ・エルエルシー |
置換型ピラゾロン化合物及び使用方法
|
|
TWI574962B
(zh)
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲ｐｉ３激酶調節劑的芳雜環化合物及其使用方法和用途
|
|
US9970002B2
(en)
|
2012-12-12 |
2018-05-15 |
Massachusetts Institute Of Technology |
Compositions and methods for functional nucleic acid delivery
|
|
KR102148681B1
(ko)
|
2013-02-21 |
2020-08-27 |
칼리토르 사이언시즈, 엘엘씨 |
Pi3 키나제 모듈레이터로서의 헤테로방향족 화합물
|
|
US10441637B2
(en)
|
2013-11-21 |
2019-10-15 |
Sena Research, Inc. |
Methods for structural determination of selenium derivatized nucleic acid complexes
|
|
WO2016011203A1
(en)
|
2014-07-15 |
2016-01-21 |
Life Technologies Corporation |
Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
|
|
CA2954475C
(en)
|
2014-07-31 |
2023-05-16 |
Uab Research Foundation |
Apoe mimetic peptides and higher potency to clear plasma cholesterol
|
|
EP3026122A1
(en)
|
2014-11-27 |
2016-06-01 |
Gentium S.p.A. |
Cellular-based method for determining the potency of defibrotide
|
|
AU2016343517B2
(en)
|
2015-10-19 |
2020-04-30 |
Sunshine Lake Pharma Co., Ltd. |
A salt of EGFR inhibitor, crystalline form and uses thereof
|
|
KR20240027874A
(ko)
|
2016-07-28 |
2024-03-04 |
리제너론 파마슈티칼스 인코포레이티드 |
Gpr156 변이체 및 이들의 용도
|
|
AU2017306422A1
(en)
|
2016-08-03 |
2019-01-31 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
TLR9 targeted therapeutics
|
|
SG11201906735RA
(en)
|
2017-01-23 |
2019-08-27 |
Regeneron Pharma |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
|
WO2018226560A1
(en)
|
2017-06-05 |
2018-12-13 |
Regeneron Pharmaceuticals, Inc. |
B4galt1 variants and uses thereof
|
|
DK3679158T3
(da)
|
2017-09-06 |
2025-06-23 |
Regeneron Pharma |
Enkelt immunoglobulin interleukin-1-receptor-relaterede (sigirr) varianter og anvendelser deraf
|
|
EP3679060A1
(en)
|
2017-09-07 |
2020-07-15 |
Regeneron Pharmaceuticals, Inc. |
Solute carrier family 14 member 1 (slc14a1) variants and uses thereof
|
|
WO2019051355A1
(en)
|
2017-09-08 |
2019-03-14 |
Ohio State Innovation Foundation |
NEW MICROARN INHIBITOR THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
|
|
KR20240125690A
(ko)
|
2017-10-11 |
2024-08-19 |
리제너론 파마슈티칼스 인코포레이티드 |
Pnpla3 i148m 변이를 발현하는 환자의 간 질환의 치료에서의 hsd17b13의 저해
|
|
AU2018352234A1
(en)
|
2017-10-16 |
2020-04-23 |
Regeneron Pharmaceuticals, Inc. |
Cornulin (CRNN) variants and uses thereof
|
|
US11957687B2
(en)
|
2019-07-02 |
2024-04-16 |
Regeneron Pharmaceuticals, Inc. |
Modulators of HSD17B13 and methods of use thereof
|
|
WO2024173343A1
(en)
|
2023-02-14 |
2024-08-22 |
Regeneron Pharmaceuticals, Inc. |
Compounds targeting hydroxysteroid 17-beta dehydrogenase (hsd17b) and uses thereof
|